VitaDAO

AMBER Tx DeSci

Strategy Notes

VitaDAO is a DeSci funding mechanism that could theoretically suit Eniola's independent researcher status and computational skills. However, it is specifically dedicated to longevity research, while Eniola's research focuses on addiction/neuropharmacology. The domain mismatch makes this a poor fit unless VitaDAO accepts cross-domain biomedical applications.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · VitaDAO exclusively funds longevity and aging research ('The autonomous organization solving aging'). All 31 funded projects are in target discovery, drug discovery, or clinical development for age-related conditions. Eniola's CCT model addresses addiction neuropharmacology — reward-memory encoding prevention — which falls entirely outside VitaDAO's stated funding domain. No cross-domain biomedical track exists.